CAPC negatively regulates NF-κB activation and suppresses tumor growth and metastasis

Oncogene

Volumn 31, Issue 13, 2012, Pages 1673-1682

  Liu, X F ^a   Xiang, L ^a   Zhang, Y ^b   Becker, K G ^b   Bera, T K ^a   Pastan, I ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

CAPC; cytokines; NF B; tumor growth

Indexed keywords

AGAR; CAPC PROTEIN; CXCL1 CHEMOKINE; CYSTATIN; CYSTATIN SN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LTB1 PROTEIN; MONOCLONAL ANTIBODY; PRSS3 PROTEIN; SERINE PROTEINASE; SMALL INTERFERING RNA; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE TARGETING; GENETIC CODE; HUMAN; HUMAN CELL; LUNG; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SALIVARY GLAND; TUMOR MICROENVIRONMENT;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NF-KAPPA B; PROSTATIC NEOPLASMS; TRANSCRIPTIONAL ACTIVATION;

MUS MUSCULUS;

EID: 84859434519     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.355     Document Type: Article

References (27)

1. American Cancer Society (2009). Cancer Facts and Figures, 2009. American Cancer Society: Atlanta, GA.
2. Apte RN, Dolan S, Elkabets M, White MR, Reich E, Carmi Y et al. (2006). The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 25: 387-408. (Pubitemid 44922357)
3. Basbaum CB, Werb Z. (1996). Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol 8: 731-738. (Pubitemid 26381732)
4. Chatterjee SK, Zetter BR. (2005). Cancer biomarkers: knowing the present and predicting the future. Future Oncol 1: 37-50.
5. Choi EH, Kim JT, Kim JH, Kim SY, Song EY, Kim JW et al. (2009). Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer. Clin Chim Acta 406: 45-51.
6. Dixit V, Mak TW. (2002). NF-κB signaling: many roads lead to Madrid. Cell 111: 615-619. (Pubitemid 35441244)
7. Egland KA, Vincent JJ, Strausberg R, Lee B, Pastan I. (2003). Discovery of the breast cancer gene BASE using a molecular approach to enrich genes encoding membrane and secreted proteins. Proc Natl Acad Sci U S A 100: 1099-1104. (Pubitemid 36183962)
8. Egland K, Liu XF, Squires S, Nagata S, Man YG, Bera TK et al. (2006). High expression of a cytokeratin-associated protein in many cancers. Proc Natl Acad Sci USA 103: 5929-5934.
9. Friedi P, Wolk K. (2008). Tube travel: the role of proteases in individual and collective cancer cell invasion. Cancer Res 68: 7247-7249.
10. Hockla A, Radisky DC, Radisky ES. (2010). Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109. Breast Cancer Res Treat 124: 27-38.
11. Joyce JA, Pollard JW. (2009). Microenvironmental regulation of metastasis. Nat Rev Cancer 9: 239-252.
12. Karin M, Greten FR. (2005). NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759. (Pubitemid 41400849)
13. Lee CH, Jeon YT, Kim SH, Song YS. (2007). NF-κB as a potential molecular target for cancer therapy. Biofactors 29: 19-35. (Pubitemid 46985299)
14. Lee M, Fridman R, Mobashery S. (2004). Extracellular proteases as targets for treatment of cancer metastases. Chem Soc Rev 10: 401-409. (Pubitemid 39456998)
15. Li F, Sethi G. (2010). Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy. Biochim Biophys Acta 1805: 167-180.
16. Loza MJ, McCall CE, Li L, Isaacs WB, Xu J et al. (2007). Assembly of inflammation-related genes for pathway-focused genetic analysis. PLoS One 2: e1035.
17. Nam JS, Kang MJ, Suchar AM, Shimamura T, Kohn EA, Michalowska AM et al. (2006). Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells. Cancer Res 66: 7176-7184. (Pubitemid 44197696)
18. Naugler WE, Karin M. (2008). NF-κB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 18: 19-26.
19. Pacifico F, Leonardi A. (2006). NF-κB in solid tumors. Biochem Pharmacol 72: 1142-1152.
20. Park BK, Zhang H, Zeng Q, Dai J, Keller ET, Giordano T et al. (2007). NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med 13: 62-69. (Pubitemid 46067387)
21. Porta C, Larghi P, Rimoldi M, Totaro MG, Allavena P, Mantovani A et al. (2009). Cellular and molecular pathways linking inflammation and cancer. Immunology 214: 761-777.
22. Raman D, Baugher PJ, Thu YM, Richmond A. (2007). Role of chemokines in tumor growth. Cancer Lett 256: 137-165. (Pubitemid 47418345)
23. Siebenlist U, Franzoso G. (1994). Structure, regulation and function of NF-κB. Annu Rev Cell Biol 10: 405-455.
24. Wang S, Liu Z, Wang L, Zhang X. (2009). NF-κB signaling pathway, inflammation and colorectal cancer. Cell Mol Immunol 6: 327-334.
25. Wu Y, Zhou BP. (2009). Inflammation: a driving force speeds cancer metastasis. Cell Cycle 8: 3267-3273.
26. Yan J, Aldrich RW. (2010). LRRC26 auxillary protein allows BK channel activation at resting voltage without calcium. Nature 466: 513-516.
27. Yoneda K, Lida H, Endo H, Ozono K, Akiyama T, Takahashi H et al. (2009). Identification of cystatin SN as a novel tumor marker for colorectal cancer. Int J Oncol 35: 33-40.